Article: A benefit/risk analysis of chronic Vioxx use: trading an ulcer for a heart attack.

Millions of people took Vioxx in the belief that it would reduce their odds of gastrointestinal damage. Few were warned by their doctors about the drug's risk of heart attack. (See related article on the next page. The following risk/benefit analysis comes from a new Web site called GoozNews (www.gooznews.com).

"November 18, 2004.At least one Food and Drug Administration official revealed her deep-seated pro-industry bias today at the Senate hearing on Vioxx. Sandra Kweder, the acting director of the Center for Drug Evaluation and Research, which is responsible for approving new drugs, dismissed concerns about the heart problems associated with the drug. They ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!